MedTrace Logo

The Use of Platelet Derived Growth Factors in Total Knee Arthroplasty, a Randomized Trial

NCT00167895 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2007-04-25

No results posted yet for this study

Summary

The objective of this study is to evaluate the effect of autologous platelet concentrate on blood loss (post-operative decrease of haemoglobin concentration), wound healing complications, range of motion, pain reduction and outcome scores when used in total knee arthroplasty.

Conditions

Interventions

PROCEDURE

Adding platelet concentrate to the wound

Sponsors & Collaborators

  • Westfries Hospital

    lead OTHER

Principal Investigators

  • Karin S Peters, MD · Slotervaart Ziekenhuis

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Completion
2006-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00167895 on ClinicalTrials.gov